Table of Content

1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Overview
1.1 Product Overview and Scope of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine
1.2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Segment by Type
1.2.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Value Comparison by Type (2023-2033)
1.2.2 Live Vaccine
1.2.3 Inactivated Vaccine
1.3 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Segment by Application
1.3.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Value by Application: (2023-2033)
1.3.2 Piglet
1.3.3 Adult Pig
1.4 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size Estimates and Forecasts
1.4.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue 2018-2033
1.4.2 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales 2018-2033
1.4.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Average Price (2018-2033)
1.5 Assumptions and Limitations
2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Competition by Manufacturers
2.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine, Product Type & Application
2.7 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Competitive Situation and Trends
2.7.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Players Market Share by Revenue
2.7.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Retrospective Market Scenario by Region
3.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size by Region: 2018 Versus 2022 Versus 2033
3.2 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Region: 2018-2033
3.2.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Region: 2018-2023
3.2.2 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Region: 2024-2033
3.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Region: 2018-2033
3.3.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Region: 2018-2023
3.3.2 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Region: 2024-2033
3.4 North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Facts & Figures by Country
3.4.1 North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size by Country: 2018 VS 2022 VS 2033
3.4.2 North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Country (2018-2033)
3.4.3 North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country (2018-2033)
3.4.4 United States
3.4.5 Canada
3.5 Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Facts & Figures by Country
3.5.1 Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size by Country: 2018 VS 2022 VS 2033
3.5.2 Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Country (2018-2033)
3.5.3 Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country (2018-2033)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size by Country: 2018 VS 2022 VS 2033
3.6.2 Asia Pacific Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Country (2018-2033)
3.6.3 Asia Pacific Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country (2018-2033)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Facts & Figures by Country
3.7.1 Latin America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size by Country: 2018 VS 2022 VS 2033
3.7.2 Latin America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Country (2018-2033)
3.7.3 Latin America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country (2018-2033)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size by Country: 2018 VS 2022 VS 2033
3.8.2 Middle East and Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Country (2018-2033)
3.8.3 Middle East and Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country (2018-2033)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Type (2018-2033)
4.1.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Type (2018-2023)
4.1.2 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Type (2024-2033)
4.1.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share by Type (2018-2033)
4.2 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Type (2018-2033)
4.2.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Type (2018-2023)
4.2.2 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Type (2024-2033)
4.2.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share by Type (2018-2033)
4.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price by Type (2018-2033)
5 Segment by Application
5.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Application (2018-2033)
5.1.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Application (2018-2023)
5.1.2 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Application (2024-2033)
5.1.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share by Application (2018-2033)
5.2 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Application (2018-2033)
5.2.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Application (2018-2023)
5.2.2 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Application (2024-2033)
5.2.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share by Application (2018-2033)
5.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price by Application (2018-2033)
6 Key Companies Profiled
6.1 CAVAC
6.1.1 CAVAC Corporation Information
6.1.2 CAVAC Description and Business Overview
6.1.3 CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Portfolio
6.1.5 CAVAC Recent Developments/Updates
6.2 Green Cross Veterinary Products
6.2.1 Green Cross Veterinary Products Corporation Information
6.2.2 Green Cross Veterinary Products Description and Business Overview
6.2.3 Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Portfolio
6.2.5 Green Cross Veterinary Products Recent Developments/Updates
6.3 Harrisvaccines
6.3.1 Harrisvaccines Corporation Information
6.3.2 Harrisvaccines Description and Business Overview
6.3.3 Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Portfolio
6.3.5 Harrisvaccines Recent Developments/Updates
6.4 Komipharm
6.4.1 Komipharm Corporation Information
6.4.2 Komipharm Description and Business Overview
6.4.3 Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Portfolio
6.4.5 Komipharm Recent Developments/Updates
6.5 Nisseiken
6.5.1 Nisseiken Corporation Information
6.5.2 Nisseiken Description and Business Overview
6.5.3 Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Portfolio
6.5.5 Nisseiken Recent Developments/Updates
6.6 Qilu Animal Health
6.6.1 Qilu Animal Health Corporation Information
6.6.2 Qilu Animal Health Description and Business Overview
6.6.3 Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Portfolio
6.6.5 Qilu Animal Health Recent Developments/Updates
6.7 Zoetis
6.6.1 Zoetis Corporation Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Portfolio
6.7.5 Zoetis Recent Developments/Updates
6.8 Wuhan Keqian
6.8.1 Wuhan Keqian Corporation Information
6.8.2 Wuhan Keqian Description and Business Overview
6.8.3 Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Portfolio
6.8.5 Wuhan Keqian Recent Developments/Updates
6.9 China Animal Husbandry Industry
6.9.1 China Animal Husbandry Industry Corporation Information
6.9.2 China Animal Husbandry Industry Description and Business Overview
6.9.3 China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Portfolio
6.9.5 China Animal Husbandry Industry Recent Developments/Updates
6.10 Luoyang Huizhong
6.10.1 Luoyang Huizhong Corporation Information
6.10.2 Luoyang Huizhong Description and Business Overview
6.10.3 Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Portfolio
6.10.5 Luoyang Huizhong Recent Developments/Updates
6.11 Shanghai Hile Bio-Technology
6.11.1 Shanghai Hile Bio-Technology Corporation Information
6.11.2 Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Description and Business Overview
6.11.3 Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Portfolio
6.11.5 Shanghai Hile Bio-Technology Recent Developments/Updates
6.12 Harbin Weike
6.12.1 Harbin Weike Corporation Information
6.12.2 Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Description and Business Overview
6.12.3 Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Portfolio
6.12.5 Harbin Weike Recent Developments/Updates
6.13 Harbin Pharmaceutical Group
6.13.1 Harbin Pharmaceutical Group Corporation Information
6.13.2 Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Description and Business Overview
6.13.3 Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Portfolio
6.13.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.14 Jiangsu Nannong
6.14.1 Jiangsu Nannong Corporation Information
6.14.2 Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Description and Business Overview
6.14.3 Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Portfolio
6.14.5 Jiangsu Nannong Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Industry Chain Analysis
7.2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Mode & Process
7.4 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Marketing
7.4.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Channels
7.4.2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Distributors
7.5 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Customers
8 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Dynamics
8.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Industry Trends
8.2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Drivers
8.3 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Challenges
8.4 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Value Comparison by Type (2023-2033) & (US$ Million)
Table 2. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Value Comparison by Application (2023-2033) & (US$ Million)
Table 3. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 17. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Region (2018-2023) & (K Units)
Table 18. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Region (2024-2033) & (K Units)
Table 20. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share by Region (2024-2033)
Table 21. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Region (2024-2033) & (US$ Million)
Table 24. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share by Region (2024-2033)
Table 25. North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 26. North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Country (2018-2023) & (K Units)
Table 27. North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Country (2024-2033) & (K Units)
Table 28. North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country (2024-2033) & (US$ Million)
Table 30. Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 31. Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Country (2024-2033) & (K Units)
Table 33. Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country (2024-2033) & (US$ Million)
Table 35. Asia Pacific Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 36. Asia Pacific Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Region (2024-2033) & (K Units)
Table 38. Asia Pacific Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Region (2024-2033) & (US$ Million)
Table 40. Latin America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 41. Latin America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Country (2024-2033) & (K Units)
Table 43. Latin America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 46. Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Country (2024-2033) & (K Units)
Table 48. Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Country (2024-2033) & (US$ Million)
Table 50. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units) by Type (2018-2023)
Table 51. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units) by Type (2024-2033)
Table 52. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share by Type (2024-2033)
Table 54. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue (US$ Million) by Type (2024-2033)
Table 56. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share by Type (2024-2033)
Table 58. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price (US$/Unit) by Type (2024-2033)
Table 60. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units) by Application (2018-2023)
Table 61. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units) by Application (2024-2033)
Table 62. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share by Application (2024-2033)
Table 64. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue (US$ Million) by Application (2024-2033)
Table 66. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share by Application (2024-2033)
Table 68. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price (US$/Unit) by Application (2024-2033)
Table 70. CAVAC Corporation Information
Table 71. CAVAC Description and Business Overview
Table 72. CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product
Table 74. CAVAC Recent Developments/Updates
Table 75. Green Cross Veterinary Products Corporation Information
Table 76. Green Cross Veterinary Products Description and Business Overview
Table 77. Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product
Table 79. Green Cross Veterinary Products Recent Developments/Updates
Table 80. Harrisvaccines Corporation Information
Table 81. Harrisvaccines Description and Business Overview
Table 82. Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product
Table 84. Harrisvaccines Recent Developments/Updates
Table 85. Komipharm Corporation Information
Table 86. Komipharm Description and Business Overview
Table 87. Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product
Table 89. Komipharm Recent Developments/Updates
Table 90. Nisseiken Corporation Information
Table 91. Nisseiken Description and Business Overview
Table 92. Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product
Table 94. Nisseiken Recent Developments/Updates
Table 95. Qilu Animal Health Corporation Information
Table 96. Qilu Animal Health Description and Business Overview
Table 97. Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product
Table 99. Qilu Animal Health Recent Developments/Updates
Table 100. Zoetis Corporation Information
Table 101. Zoetis Description and Business Overview
Table 102. Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product
Table 104. Zoetis Recent Developments/Updates
Table 105. Wuhan Keqian Corporation Information
Table 106. Wuhan Keqian Description and Business Overview
Table 107. Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product
Table 109. Wuhan Keqian Recent Developments/Updates
Table 110. China Animal Husbandry Industry Corporation Information
Table 111. China Animal Husbandry Industry Description and Business Overview
Table 112. China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product
Table 114. China Animal Husbandry Industry Recent Developments/Updates
Table 115. Luoyang Huizhong Corporation Information
Table 116. Luoyang Huizhong Description and Business Overview
Table 117. Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product
Table 119. Luoyang Huizhong Recent Developments/Updates
Table 120. Shanghai Hile Bio-Technology Corporation Information
Table 121. Shanghai Hile Bio-Technology Description and Business Overview
Table 122. Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product
Table 124. Shanghai Hile Bio-Technology Recent Developments/Updates
Table 125. Harbin Weike Corporation Information
Table 126. Harbin Weike Description and Business Overview
Table 127. Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product
Table 129. Harbin Weike Recent Developments/Updates
Table 130. Harbin Pharmaceutical Group Corporation Information
Table 131. Harbin Pharmaceutical Group Description and Business Overview
Table 132. Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product
Table 134. Harbin Pharmaceutical Group Recent Developments/Updates
Table 135. Jiangsu Nannong Corporation Information
Table 136. Jiangsu Nannong Description and Business Overview
Table 137. Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product
Table 139. Jiangsu Nannong Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Distributors List
Table 143. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Customers List
Table 144. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Trends
Table 145. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Drivers
Table 146. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Challenges
Table 147. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine
Figure 2. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Value Comparison by Type (2023-2033) & (US$ Million)
Figure 3. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Share by Type in 2022 & 2033
Figure 4. Live Vaccine Product Picture
Figure 5. Inactivated Vaccine Product Picture
Figure 6. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Value Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Share by Application in 2022 & 2033
Figure 8. Piglet
Figure 9. Adult Pig
Figure 10. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 11. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size (2018-2033) & (US$ Million)
Figure 12. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (2018-2033) & (K Units)
Figure 13. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price (US$/Unit) & (2018-2033)
Figure 14. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Report Years Considered
Figure 15. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Players: Market Share by Revenue in 2022
Figure 18. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Figure 20. North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share by Country (2018-2033)
Figure 21. North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share by Country (2018-2033)
Figure 22. United States Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 23. Canada Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 24. Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share by Country (2018-2033)
Figure 25. Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share by Country (2018-2033)
Figure 26. Germany Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 27. France Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 28. U.K. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 29. Italy Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 30. Russia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 31. Asia Pacific Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share by Region (2018-2033)
Figure 32. Asia Pacific Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share by Region (2018-2033)
Figure 33. China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 34. Japan Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 35. South Korea Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 36. India Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 37. Australia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 38. China Taiwan Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 40. Latin America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share by Country (2018-2033)
Figure 41. Latin America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share by Country (2018-2033)
Figure 42. Mexico Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 43. Brazil Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 44. Argentina Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 45. Colombia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share by Country (2018-2033)
Figure 47. Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share by Country (2018-2033)
Figure 48. Turkey Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 50. UAE Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 51. Global Sales Market Share of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine by Type (2018-2033)
Figure 52. Global Revenue Market Share of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine by Type (2018-2033)
Figure 53. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price (US$/Unit) by Type (2018-2033)
Figure 54. Global Sales Market Share of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine by Application (2018-2033)
Figure 55. Global Revenue Market Share of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine by Application (2018-2033)
Figure 56. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price (US$/Unit) by Application (2018-2033)
Figure 57. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Value Chain
Figure 58. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed